Question 1

What is the catalog number for LRIT3 (Leucine-rich Repeat, Immunoglobulin-like Domain and Transmembrane Domain-containing Protein 3, FIGLER4, FLJ44691, MGC120618) (APC)?

Accepted Answer

The catalog number for LRIT3 (Leucine-rich Repeat, Immunoglobulin-like Domain and Transmembrane Domain-containing Protein 3, FIGLER4, FLJ44691, MGC120618) (APC) is 129202-APC.

Question 2

What sizes are available for LRIT3 (Leucine-rich Repeat, Immunoglobulin-like Domain and Transmembrane Domain-containing Protein 3, FIGLER4, FLJ44691, MGC120618) (APC)?

Accepted Answer

LRIT3 (Leucine-rich Repeat, Immunoglobulin-like Domain and Transmembrane Domain-containing Protein 3, FIGLER4, FLJ44691, MGC120618) (APC) is available in the following size(s): 100 µL.

Question 3

Is LRIT3 (Leucine-rich Repeat, Immunoglobulin-like Domain and Transmembrane Domain-containing Protein 3, FIGLER4, FLJ44691, MGC120618) (APC) in stock?

Accepted Answer

LRIT3 (Leucine-rich Repeat, Immunoglobulin-like Domain and Transmembrane Domain-containing Protein 3, FIGLER4, FLJ44691, MGC120618) (APC)

Selected Variant

129202-APC

Size: 100 µL

Product Specifications

Clonality

Mab

Question 4

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Question 5

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 6

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.